Cormorant Asset Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,050,000	Closed	-$17.5M	–	74
2023 Q1	$17.5M	Buy	1,050,000 +350,000	+50%	+$5.83M	1.15%	25
2022 Q4	$6.58M	Buy	+700,000	New	+$6.58M	0.44%	48